摘要
目的:观察补阳还五汤辅治中风后遗症(SS)的临床疗效。方法:60例采用单双数抽签法分为对照组与观察组各30例。两组均用常规治疗并给予阿司匹林,观察组加用补阳还五汤。结果:治疗6周后观察组总有效率高于对照组(P<0.05)。观察组全血高切黏度、全血低切黏度、血浆黏度小于对照组,纤维蛋白原(FIB)水平低于对照组(P<0.05);观察组的高敏-C反应蛋白(hs-CRP)、白介素(I)L-6、IL-8及肿瘤坏死因子-α(TNF-α)水平低于对照组(P<0.05);观察组的欧洲卒中量表(ESS)评分、Fugl-Meyer评定量表(FMA)评分、日常生活能力量表(ADL)评分均高于对照组(P<0.05)。结论:补阳还五汤辅治SS效果较好。
Objective:To observe the clinical effect of Buyang Huanwu Decoction in the treatment of stroke sequelae(SS).Methods:Sixty cases were divided into the control group and the observation group by single and double number lottery method,30 cases in each group.Both groups were treated with routine treatment and aspirin,and the observation group were treated with Buyang Huanwu Decoction.Results:After 6 weeks of treatment,the total effective rate of the observation group was higher than that of the control group(P<0.05).The whole blood high shear viscosity,whole blood low shear viscosity and plasma viscosity in the observation group were lower than those in the control group,and the fibrinogen(FIB)level was lower than that in the control group(P<0.05).The levels of hs-CRP,IL-6,IL-8 and TNF-αin the observation group were lower than those in the control group(P<0.05).The scores of European Stroke Scale(ESS),Fugl-Meyer Assessment(FMA)and Activity of Daily Living(ADL)in the observation group were higher than those in the control group(P<0.05).Conclusion:Buyang Huanwu Decoction is effective in treating SS.
出处
《实用中医药杂志》
2023年第1期71-73,共3页
Journal of Practical Traditional Chinese Medicine
基金
吉安市2022年指导性科技计划(20222-026938)。
关键词
中风后遗症
补阳还五汤
对照治疗观察
Stroke sequelae
Buyang Huanwu Decoction
Control treatment and observation